NeoGraph Analytics
Medical ImagingNorth America2023 – 2032

Global Medical Imaging AI Market Analysis, Opportunities and Forecast 2024-2032

Global Medical Imaging AI market valued at USD 1.4B in 2023, projected to reach USD 8.7B by 2032 at 22.5% CAGR.

Revenue, 2023

$1.4B

Forecast, 2032

$8.7B

CAGR, 2024-2032

22.5%

Report Coverage

North America

Code: medical-imaging-ai-marketPublished: 2026Pages: 150+Format: PDF + Excel
01

Executive Summary

The global medical imaging AI market, valued at USD 1.4 billion in 2023, is projected to reach USD 8.7 billion by 2032, growing at a CAGR of 22.5%. Key growth drivers include persistent radiologist shortages, rising diagnostic imaging volumes exceeding 30% growth over five years, and rapid FDA clearances for AI-powered diagnostic tools. North America dominates with 42% market share, while Asia Pacific emerges as the fastest-growing region at 28.5% CAGR. Radiology AI applications command 40% of the market. Major players like GE Healthcare, Siemens Healthineer, and Aidoc are investing heavily in cloud-native platforms and FDA-cleared solutions.

02

Key Highlights

1

Market projected to grow from USD 1.4B in 2023 to USD 8.7B by 2032 at a 22.5% CAGR.

2

Radiology AI dominates with 40% share, driven by radiologist shortages and escalating imaging volumes.

3

North America leads with 42% share; Asia Pacific is fastest-growing at 28.5% CAGR.

03

Market Overview

Market Context

Medical imaging AI integrates deep learning, computer vision, and clinical data to enhance diagnostic accuracy and workflow efficiency across radiology, pathology, and cardiology. Rising imaging volumes, specialist shortages, and regulatory approvals are accelerating adoption. Cloud-native architectures and embedded AI hardware are expanding the addressable market beyond pure software into full-platform solutions.

Medical imaging AI leverages deep learning and computer vision to enhance diagnostic accuracy and workflow efficiency. The market is in a high-growth stage, with core software and services valued at USD 1.4B in 2023 and broader platform solutions exceeding USD 2B. Cloud-native architectures and embedded AI hardware are expanding the addressable market rapidly.

Market Stage

High growth

Adoption Level

Growing

Key Trends

Cloud-native AI platforms replacing traditional on-premise PACS integrationsFDA SaMD clearances accelerating with 500+ AI-enabled devices approved by 2024Multimodal AI combining imaging with EHR and genomic data for precision diagnosticsEmerging markets in Asia Pacific and Latin America driving new adoption frontiers
04

Market Forecast & Data

Market Growth Forecast
2024-2032 · CAGR 22.5%

Base Year (2023)

$1.4B

Forecast (2032)

$8.7B

CAGR (2024-2032)

22.5%

Market size by year, 2024-2032, in USD Billion.
YearMarket size ($ Billion)
2023Base year$1.40B
2024$1.72B
2025$2.10B
2026$2.57B
2027$3.15B
2028$3.86B
2029$4.73B
2030$5.80B
2031$7.10B
2032$8.70B
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Forecast Analysis

The 22.5% CAGR reflects sustained demand for AI-assisted diagnostics, workflow automation, and triage prioritization. Radiology AI leads adoption, but pathology and ophthalmology segments are gaining traction. Cloud deployment dominates at 55% share and is expected to grow further. Asia Pacific's high growth is driven by expanding healthcare infrastructure and government digitization initiatives.

Regional Market Analysis
Market share and growth rate by region
Regional market analysis — market share, growth rate and largest market by region.
RegionMarket shareGrowth rateLargest market
North America42.0%20.5%United States
Europe28.0%22.0%Germany
Asia Pacific30.0%28.5%China

North America

#1
Share: 42.0%CAGR: 20.5%

Largest market: United States

Europe

#2
Share: 28.0%CAGR: 22.0%

Largest market: Germany

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
05

Market Dynamics

  • Persistent radiologist shortage and rising imaging volumes exceeding 30% growth
  • Accelerating FDA clearances for AI/ML-based diagnostic software
  • Growing demand for automated triage and workflow optimization
06

Market Segmentation

By Application
Market share distribution across 5 segments
By Application — market share by segment, in percent.
SegmentShare
Radiology AILargest segment covering CT, MRI, and X-ray AI applications for detection, diagnosis, and workflow automation.40.0%
Pathology AIAI-powered digital pathology for cancer detection, tissue analysis, and biomarker quantification.20.0%
Cardiology AIAI applications for echocardiography, cardiac MRI analysis, and coronary artery assessment.15.0%
Ophthalmology AIRetinal imaging AI for diabetic retinopathy screening, glaucoma detection, and macular degeneration analysis.15.0%
Other SpecialtiesDermatology AI, obstetric ultrasound AI, and other emerging imaging AI applications.10.0%
Total100.0%
Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.

By End User

  • Hospitals
  • Diagnostic Imaging Centers
  • Research Institutes
  • Clinics
07

Regional Analysis

1

North America

Lead: United States
CAGR: 20.5%Share: 42.0%

Dominant market driven by advanced healthcare infrastructure, high imaging volumes, and strong FDA pipeline of AI-enabled devices.

2

Europe

Lead: Germany
CAGR: 22.0%Share: 28.0%

Growing adoption supported by EU MDR regulatory clarity, government healthcare digitization programs, and major OEM presence.

3

Asia Pacific

Lead: China
CAGR: 28.5%Share: 30.0%

Fastest-growing region driven by expanding healthcare infrastructure, government AI initiatives, and large underserved patient populations.

Country-Level Analysis

Source: NeoGraph Analytics, tabulated from the base-year and forecast values stated in this report. How these figures are produced.
Market share and growth rate by country
CountryShareGrowth
United States
38.0%
+21.0%
Germany
12.0%
+20.5%
China
18.0%
+30.0%
08

Competitive Landscape

G

GE Healthcare

United States

Leader19.6B

Global market leader with the Edison AI platform spanning CT, MRI, and ultrasound, bolstered by the MIM Software acquisition for advanced imaging analytics and radiation therapy planning.

Global leader in medical imaging AI with the Edison platform spanning CT, MRI, and ultrasound modalities, enhanced by the MIM Software acquisition.

S

Siemens Healthineer

Germany

Challenger22.4B

Strong AI portfolio including AI-Rad Companion for cloud-based imaging analysis, with significant R&D investment in molecular imaging and integrated diagnostics.

Major challenger with AI-Rad Companion for cloud-based imaging analysis and deep investment in molecular imaging and integrated diagnostics.

A

Aidoc

Israel

Emerging100M

Leading pure-play AI startup with FDA-cleared triage solutions deployed in 900+ hospitals globally, specializing in acute condition detection including stroke and pulmonary embolism.

Leading pure-play AI startup with FDA-cleared triage solutions deployed in over 900 hospitals globally, specializing in acute condition detection.

09

Recent Developments

25
2025GE Healthcare

Launched next-generation TrueFidelity CT AI platform with 40% faster image reconstruction and expanded deep-learning noise reduction.

24
2024Aidoc

Surpassed 900 hospital deployments globally and secured FDA clearance for its AI Operating System (aiOS) platform.

10

Regulatory Landscape

FDA AI/ML-Based Software as a Medical Device (SaMD) Action Plan with predetermined change control protocolsEU Medical Device Regulation (MDR) 2017/745 requiring clinical evidence and post-market surveillance for AI-enabled imaging devices
11

Research Methodology

Primary research

  • Expert interviews with radiologists, hospital CIOs, and AI platform vendors
  • Surveys of diagnostic imaging centers across North America, Europe, and Asia Pacific

Secondary research

  • Industry reports from MarketsandMarkets, Emergen Research, and Lucintel
  • Company financials, SEC filings, and investor presentations

Validation: Triangulation method

12

Strategic Takeaways

Investors

Strong 22.5% CAGR and expanding addressable market present compelling opportunities in radiology AI and cloud-native diagnostic platforms.

Operators

Adopting AI-powered imaging tools is essential to address radiologist shortages, reduce diagnostic turnaround times, and improve throughput.

13

Frequently Asked Questions

Reports in the same field, each with its base-year figure and the growth rate it is published at.